The great thing about biotech companies is that the medicines they develop are always in need, in good times and bad. But to remain successful, drugmakers have to continue innovating. The most prominent players in the biotech industry are often those with solid pipelines that allow them to earn new approvals regularly.

And in that department, few biotechs can hold a candle to Eli Lilly (NYSE: LLY), which stands as one of the largest companies in the industry. Eli Lilly's ability to develop new and exciting products is one of the key reasons it's one of the best biotechs to invest in right now, but it isn't the only reason. Let's dig in. 

Contrary to the broader market, Eli Lilly has performed exceedingly well over the past 12 months, with the company's shares up by 32% in this period.

Continue reading

Source Fool.com